| _version_ |
1860799353995657216
|
| building |
INTELEK Repository
|
| collection |
Online Access
|
| collectionurl |
https://intelek.unisza.edu.my/intelek/pages/search.php?search=!collection407072
|
| date |
2018-07-29 09:30:42
|
| eventvenue |
Kuala Lumpur, Malaysia
|
| format |
Restricted Document
|
| id |
5673
|
| institution |
UniSZA
|
| originalfilename |
1570-01-FH03-FP-18-17437.pdf
|
| recordtype |
oai_dc
|
| resourceurl |
https://intelek.unisza.edu.my/intelek/pages/view.php?ref=5673
|
| spelling |
5673 https://intelek.unisza.edu.my/intelek/pages/view.php?ref=5673 https://intelek.unisza.edu.my/intelek/pages/search.php?search=!collection407072 Restricted Document Conference Conference Paper application/pdf 1 Adobe Acrobat Pro DC 20 Paper Capture Plug-in 1.7 2018-07-29 09:30:42 1570-01-FH03-FP-18-17437.pdf UniSZA Private Access TCI remifentanil for fetal immobiliztion and analgesia during Ex-Utero Intrapartum (EXIT) Surgical Airway for fetal with congenital high airway obstruction syndrome (CHAOS). In performing a delicate fetal airway surgery, the fetal must achieve adequate analgesia and more importantly immobilization. There are several ways of achieving fetal analgesia and immobilization during EXIT procedure which include direct administration of analgesics and muscle relaxant to fetal via intravenous or intramuscular route, intra-amniotic delivery or delivery through maternal infusion. In our case, fetal analgesia and immobilization was achieved through maternal target controlled infusion of remifentanil supplemented with inhalational sevoflurane. World Congress of SIVA-TCI 2018 Kuala Lumpur, Malaysia
|
| spellingShingle |
TCI remifentanil for fetal immobiliztion and analgesia during Ex-Utero Intrapartum (EXIT) Surgical Airway for fetal with congenital high airway obstruction syndrome (CHAOS).
|
| summary |
In performing a delicate fetal airway surgery, the fetal must achieve adequate analgesia and more importantly immobilization. There are several ways of achieving fetal analgesia and immobilization during EXIT procedure which include direct administration of analgesics and muscle relaxant to fetal via intravenous or intramuscular route, intra-amniotic delivery or delivery through maternal infusion. In our case, fetal analgesia and immobilization was achieved through maternal target controlled infusion of remifentanil supplemented with inhalational sevoflurane.
|
| title |
TCI remifentanil for fetal immobiliztion and analgesia during Ex-Utero Intrapartum (EXIT) Surgical Airway for fetal with congenital high airway obstruction syndrome (CHAOS).
|
| title_full |
TCI remifentanil for fetal immobiliztion and analgesia during Ex-Utero Intrapartum (EXIT) Surgical Airway for fetal with congenital high airway obstruction syndrome (CHAOS).
|
| title_fullStr |
TCI remifentanil for fetal immobiliztion and analgesia during Ex-Utero Intrapartum (EXIT) Surgical Airway for fetal with congenital high airway obstruction syndrome (CHAOS).
|
| title_full_unstemmed |
TCI remifentanil for fetal immobiliztion and analgesia during Ex-Utero Intrapartum (EXIT) Surgical Airway for fetal with congenital high airway obstruction syndrome (CHAOS).
|
| title_short |
TCI remifentanil for fetal immobiliztion and analgesia during Ex-Utero Intrapartum (EXIT) Surgical Airway for fetal with congenital high airway obstruction syndrome (CHAOS).
|
| title_sort |
tci remifentanil for fetal immobiliztion and analgesia during ex-utero intrapartum (exit) surgical airway for fetal with congenital high airway obstruction syndrome (chaos).
|